SCHEMBL582376

SCHEMBL582376

CCn1ncc2c(NCc3ccccc3)c(C3=NOC4(CCC4)C3)cnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 6/20 0.42
ADORA1 P30542 5/20 0.39
ADORA2A P29274 1/20 0.39
PDE5A O76074 3/20 0.38
LMNA P02545 3/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDE7A Q13946 1/20 0.37
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SRC P12931 2/20 0.34
ABL1 P00519 1/20 0.34
FYN P06241 1/20 0.34
YES1 P07947 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL582190 0.88 PDE4B (0.48) PDE4BALDH1A1HPGDPDE7AABL1
SCHEMBL583252 0.86 PDE4B (0.48) PDE4BPDE7AABL1
SCHEMBL1943889 0.85 PDE4B (0.44) PDE4BADORA1ADORA2APDE5ALMNA
SCHEMBL582884 0.85 PDE4B (0.48) PDE4BPDE7AABL1
SCHEMBL582601 0.83 PDE4B (0.38) PDE4BPDE7ASRCLYN
SCHEMBL583350 0.82 PDE4B (0.39) PDE4BPDE5AHPGDPDE7AMEN1
SCHEMBL582472 0.81 PDE4B (0.39) PDE4BPDE5APDE7AABL1
SCHEMBL583012 0.81 PDE4B (0.50) PDE4BPDE7A
SCHEMBL582443 0.81 PDE4B (0.39) PDE4BPDE5AHPGDPDE7AMEN1
SCHEMBL582598 0.81 PDE4B (0.38) PDE4BPDE7ASRCLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420666-B2 Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors RANBAXY LABORATORIES LIMITED (IN) 2013-04-16 US disclosed
EP-2124944-B1 Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors RANBAXY LAB LTD (IN) 2012-02-15 EP disclosed
US-20100292196-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292196-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS PDE3B, PDE4A, PDE3A PDE4B 5/4885ADORA1 1009/4885ADORA2A 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.